Jyothy Labs Limited — PPTs, 12-05-2025: Investor Presentation

1. Financial Highlights:

Jyothy Labs reported FY25 revenue of Rs 2,847 Cr, up 3.3% YoY, driven by 6.4% volume growth. Gross margin improved to 50.1%, while EBITDA rose 4.1% to Rs 500 Cr with a 17.5% margin. PAT remained steady at Rs 370 Cr, with margin edging up to 13.0%. Q4 revenue increased 1.1% to Rs 667 Cr; EBITDA margin improved to 16.8%, and PAT was Rs 76.3 Cr. Operating working capital days declined to 18, and cash reserves rose to Rs 757 Cr. ROE (ex-goodwill) was 29.3%.

2. Strategic Initiatives & Growth Drivers:

Significant expansion in liquid detergent portfolio (3x increase) and direct reach rose by 100k outlets to 1.3 million, supporting a total outlet reach of 3.6 million. New launches included Ujala fabric conditioner, Maxo aerosol/racquet, and Jovia body soap, targeting category expansion and deeper penetration in southern and urban markets. Marketing ramp-up featured celebrity endorsements and strong ATL/digital campaigns, especially for core brands. Continued investments in capex and automation focus on sustainability with solar plants and zero liquid discharge.

3. Business Developments:

No acquisitions or partnerships disclosed. Focus remained on portfolio innovation across fabric care, dishwashing, household insecticides, and personal care. Product introductions include Margo handwash mega pack and Maxo aerosol variants to reinforce insecticide category offerings.

4. Market Position & Competitive Advantage:

Jyothy Labs leads the fabric whitening segment and holds a solid second place in dishwash (by value) and mosquito coils. A pan-India footprint with 23 plants and over 9,900 channel partners supports scale and distribution advantages. Aggressive brand-building and targeted campaigns help strengthen consumer loyalty and market share.

5. Investor Implications:

Steady volume growth and margin improvements signal positive growth potential. Strong brand presence, expanded direct reach, and ongoing innovation provide sustainable top-line momentum. Execution risks stem from subdued urban demand and intense competition. Cost efficiencies and selective pricing actions offer margin support amid inflation. Overall, the company is positioned for steady expansion backed by a robust balance sheet and healthy cash position.